Structure of Mycobacterial NDH-2 Bound to a 2-Mercapto-Quinazolinone Inhibitor
Mycobacterial type II NADH dehydrogenase (NDH-2) is a promising drug target because of its central role in energy metabolism in Mycobacterium tuberculosis and other pathogens, and because it lacks a k...
Now published J. Med. Chem! @zestytoast.bsky.social's structure of type II NADH dehydrogenase from mycobacteria. A promising drug target for TB & other mycobacterial infections, Yingke demonstrates how an inhibitor can block transfer of electrons from NADH to the ETC.
pubs.acs.org/doi/full/10....
21.03.2025 16:55
๐ 24
๐ 10
๐ฌ 2
๐ 0
Public domain photo of Banff national park in Alberta, Canada.
๐จ Amazing Opportunity ๐จ
U Alberta is looking for a director for their new #cryoEM facility
Support excellent researchers (who are really nice people) using state-of-the-art infrastructure.
+ reasonable cost of living
+ near some of most beautiful places in world
+ ๐จ๐ฆ
apps.ualberta.ca/careers/post...
22.02.2025 02:47
๐ 210
๐ 50
๐ฌ 3
๐ 4
Cryo-EM map and atomic model of the RAVE complex (regulator of ATPases of endosomes and vacuoles) bound to a partial V1-ATPase complex
Atomic model showing that the RAVE complex binds to a region of the V1 complex subunit A not found in the homologous ATP synthase subunit beta.
Most protein complexes are born only once. V-ATPase assembles over and over as part of its regulatory mechanism, enabled by RAVE (regulator of ATPase of vacuoles and endosomes)
@hanlinw222.bsky.social's 1st struct of RAVE bound to a partial V1 complex now out in PNAS.
www.pnas.org/doi/10.1073/...
03.12.2024 19:34
๐ 62
๐ 14
๐ฌ 1
๐ 0